0000899243-16-017315.txt : 20160401 0000899243-16-017315.hdr.sgml : 20160401 20160401161526 ACCESSION NUMBER: 0000899243-16-017315 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160401 DATE AS OF CHANGE: 20160401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUEHL DANIEL W CENTRAL INDEX KEY: 0001283569 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 161547317 MAIL ADDRESS: STREET 1: 5 BILLERICA PARK STREET 2: 101 BILLERICA AVE CITY: NORTH BILLERCA STATE: MA ZIP: 01862 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-03-31 0 0001466301 Clovis Oncology, Inc. CLVS 0001283569 MUEHL DANIEL W C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY BOULDER CO 80301 0 1 0 0 See remarks Stock option (right to buy) 84.83 2025-07-06 Common Stock 35000 D Stock option (right to buy) 19.37 2026-03-01 Common Stock 5000 D Stock option (right to buy) 19.37 2026-03-01 Common Stock 7500 D Restricted Stock Units 2026-03-01 Common Stock 2500 D The option shall vest as to 25% of the shares on July 6, 2016, and the remainder shall vest in substantially equal installments over the 48 months immediately following such date. The option shall vest as to 50% of the shares on March 1, 2017, and the remainder shall vest on March 1, 2018. The restricted stock units shall vest as to 50% of the units on March 1, 2017, and the remainder shall vest on March 1, 2018. Each restricted stock unit represents the right to receive one share of Common Stock. Vice President of Finance, Principal Financial Officer and Principal Accounting Officer /s/ Daniel W. Muehl 2016-04-01